Updated Jul 16, 2026
ROTHBLATT MARTINE A has filed 58 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $864K. Lifetime open-market sales: $489.82M.

Martine A. Rothblatt is an American biotech entrepreneur, attorney, author, and advocate. She is best known as the founder of United Therapeutics Corporation, a public biotechnology company focused on treatments for pulmonary arterial hypertension and other diseases. Rothblatt is also recognized for co-founding Sirius Satellite Radio (which evolved into Sirius XM Holdings) and for her public advocacy on transgender rights. In addition to her business ventures, she has been involved in the Terasem movement, which explores life extension, digital immortality, and related technologies. Rothblatt has authored books and contributed to discussions at the intersection of science, law, and social policy.
| Role | Insider |
|---|---|
| Notability | 90/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 200 | $532.60 | $107K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 107 | $531.08 | $57K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 554 | $530.67 | $294K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 959 | $529.21 | $508K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 660 | $528.13 | $349K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 1.2K | $527.06 | $643K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 3.5K | $526.13 | $1.84M |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 1.5K | $525.16 | $771K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 840 | $524.15 | $440K |
| 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | M — Option exercise [10b5-1] | 9.5K | $135.42 | $1.29M |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 40 | $542.80 | $22K |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 360 | $541.10 | $195K |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 320 | $539.60 | $173K |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 409 | $538.60 | $220K |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 665 | $537.66 | $358K |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 2.2K | $536.52 | $1.19M |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 2.2K | $535.47 | $1.17M |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 2.3K | $534.63 | $1.21M |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale [10b5-1] | 1.0K | $533.70 | $544K |
| 2026-07-14 | UTHR | UNITED THERAPEUTICS Corp | M — Option exercise [10b5-1] | 9.5K | $135.42 | $1.29M |
Martine A. Rothblatt is an American biotech entrepreneur, attorney, author, and advocate. She is best known as the founder of United Therapeutics Corporation, a public biotechnology company focused on treatments for pulmonary arterial hypertension and other diseases. Rothblatt is also recognized for co-founding Sirius Satellite Radio (which evolved into Sirius XM Holdings) and …
58 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($864K) and 997 open-market sales ($489.82M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ROTHBLATT MARTINE A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.